Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients

♦ BACKGROUND: The pro-inflammatory receptor of advanced glycation end-products (RAGE)-ligand S100A12 is thought to promote, whereas anti-inflammatory soluble RAGE (sRAGE) may protect against, vascular disease. We evaluated circulating S100A12 and sRAGE in relation to vascular disease, inflammation,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Perit Dial Int
Autors principals: Isoyama, Naohito, Machowska, Anna, Qureshi, Abdul Rashid, Yamamoto, Tae, Anderstam, Björn, Heimburger, Olof, Barany, Peter, Stenvinkel, Peter, Lindholm, Bengt
Format: Artigo
Idioma:Inglês
Publicat: Multimed Inc 2016
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4881789/
https://ncbi.nlm.nih.gov/pubmed/26493750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/pdi.2014.00121
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars